Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results.
Pierre-Yves Litzler, Alain Manrique, Manuel Etienne, Alice Salles, Agathe Edet-Sanson, Pierre Vera, Jean-Paul Bessou, Anne Hitzel
Index: J. Nucl. Med. 51(7) , 1044-8, (2010)
Full Text: HTML
Abstract
We report our experience with using integrated molecular and anatomic hybrid imaging to assess infection in patients who have a left-ventricular-assist device (LVAD).Thirteen (99m)Tc-exametazime-leukocyte planar and SPECT/CT scans were obtained for 8 consecutive patients who had an implanted LVAD. SPECT/CT was used to assess suspected device-related infections (n = 8) and to evaluate the efficiency of current antibiotic therapy (n = 5).Device-related infection was seen on 8 of the 13 scans. SPECT/CT was positive for infection in all 8 patients, whereas planar scans were positive in 6 of 8. SPECT/CT provided relevant information on the extent of infection and its exact location in all patients. Additional distant infectious foci were demonstrated in 3 of 13 patients.SPECT/CT led to an accurate diagnosis of LVAD-related infection, revealing both anatomic location and extent. This noninvasive approach could lead to improved therapeutic strategies.
Related Compounds
Related Articles:
2003-08-08
[J. Pharm. Biomed. Anal. 32(4-5) , 679-85, (2003)]
2008-04-15
[Neuroimage 40(3) , 1056-63, (2008)]
Chiral ligand-exchange chromatography for diastereo-enantio separation of exametazime.
2003-08-21
[J. Pharm. Biomed. Anal. 32(6) , 1159-66, (2003)]
1994-12-01
[J. Nucl. Med. 35(12) , 2003-10, (1994)]
2013-04-01
[J. Cereb. Blood Flow Metab. 33(4) , 612-8, (2013)]